Related Experiment Video

Updated: Jun 18, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

652

Exercise leads to better sleep in children with inflammatory bowel disease

Ivana Trivić Mažuranić1, Sara Sila1, Zrinjka Mišak1,2

  • 1Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, Zagreb, Croatia.

Pediatrics International : Official Journal of the Japan Pediatric Society
|July 30, 2024
PubMed

Insights

A 6-month exercise program for children with inflammatory bowel disease (IBD) significantly improved sleep quality but did not significantly enhance health-related quality of life (HRQoL). This study highlights the benefits of exercise for pediatric IBD patients.

Area of Science:

  • Pediatric gastroenterology
  • Exercise science
  • Quality of life research

Background:

  • Children with inflammatory bowel disease (IBD) often experience impaired health-related quality of life (HRQoL) and sleep disturbances.
  • Remission in pediatric IBD does not always restore optimal physical function or well-being.

Purpose of the Study:

  • To investigate the impact of a 6-month home-based exercise program on HRQoL and sleep quality in pediatric IBD patients in remission.
  • To objectively assess physical activity levels before and after the intervention.

Main Methods:

  • 42 pediatric IBD patients (mean age 15.3 years, 25 boys; 22 Crohn's disease, 18 ulcerative colitis) completed a 6-month home-based exercise program.
  • Health-related quality of life (HRQoL) was measured using the IMPACT III questionnaire.
  • Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), and physical activity (PA) was objectively measured using accelerometers.

Main Results:

  • No statistically significant improvement in HRQoL scores (IMPACT III) was observed post-intervention (p=0.106).
  • The prevalence of impaired sleep quality (PSQI > 5) significantly decreased from 30.9% to 23.8% (p=0.027).
  • Baseline light physical activity (LPA) correlated positively with HRQoL (p=0.013). Post-intervention, changes in HRQoL correlated positively with moderate-to-vigorous PA (MVPA) (p=0.047) and negatively with changes in PSQI scores (p=0.001).

Conclusions:

  • A 6-month home-based resistance training program significantly reduced impaired sleep quality in pediatric IBD patients in remission.
  • While HRQoL improvements did not reach statistical significance, correlations suggest a link between increased physical activity and better HRQoL and sleep outcomes.
Abstract

Keywords:
childinflammatory bowel diseasephysical activityquality of lifesleep

More Related Videos

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.2K
Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood08:20

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood

Published on: October 2, 2019

11.9K

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
110
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
138
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
124
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124